Status:
COMPLETED
Non-thermal Plasma for Sebum Reduction in Oily Facial Skin
Lead Sponsor:
Gangnam Severance Hospital
Conditions:
Oily Skin
Eligibility:
All Genders
19-40 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the efficacy and safety of argon-and nitrogen- non-thermal, atmospheric-pressure plasma (NTAPP) for reduction of sebum excretion in healthy volunteers with oily fa...
Detailed Description
Excessive secretion of sebum contributes to several skin diseases associated with sebum glands, including acne. Excessive sebum secretion can damage the skin barrier function by changing the compositi...
Eligibility Criteria
Inclusion
- Persons aged 19 to 40 years who are determined to have oily skin type. Skin types were classified based on the sebum measurements by using measured using a Sebumeter® (SM815; Courage+Khazaka Electronic GmbH, Cologne, Germany) according to the manufacturer's guidelines as follows: \> 220 μg/cm2 on forehead and \> 180 μg/cm2 on cheeks, oily type; 100-220 μg/cm2 on forehead and 70-180 μg/cm2 on cheeks, normal type; \< 100 μg/cm2 on forehead and \< 70 μg/cm2 on cheeks, dry type.
- People with mild acne-like skin whose upper limit is Grade 1 (Few lesions; No nodules, papules/pustules less than 1, few comedones) and Grade 2(Mild; No nodules, papules/pustules less than 5, some comedones) of the Korean acne severity system
- Persons who skin color of type I to III according to Fitzpatrick skin type
- Persons who do not have inflammatory skin diseases on the facial skin
- Persons who have heard the purpose and contents of a clinical trial and voluntarily signed the consent form prior to the clinical trial
- Persons who can be monitored during a clinical trial period
Exclusion
- Persons who do not want this study or do not write a consent form
- Persons who have a history of hypertrophic scars, keloids, etc.
- Persons who have been using retinoid formulations within the last 1 month due to excessive sebum secretion or acne
- Persons who have a history of receiving treatments such as lasers or fillers on your face within the last 1 month
- Persons who is pregnant or lactating, or have a pregnancy plan within the expected trial period
- Other cases in which the study is considered difficult due to the judgment of the principal investigator
Key Trial Info
Start Date :
November 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 6 2020
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04917835
Start Date
November 15 2019
End Date
May 6 2020
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GangnamSeverance Hospital
Seoul, South Korea